Data / Drug companies / Jubilant Biosys Limited
Jubilant Biosys Limited: 96 products in the FDA NDC directory, labeler code 65372
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Jubilant Biosys Limited (labeler code 65372) lists 96 products in the FDA National Drug Code Directory. By type: 96 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on June 19, 2026.
The request: Watch Jubilant Biosys Limited (FDA labeler code 65372): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 65372
- Products in commercial distribution
- 96
- Packages
- 104
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Controlled substance products
- Schedule IV 2, Schedule V 1
- Started marketing in the last 12 months
- 1
- Earliest marketing start
- September 21, 1999
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 96 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 96 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 96 | 100% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Carbamazepine | 65372-1210 | Powder | Bulk ingredients | June 19, 2026 |
| Varenicline tartrate | 65372-1199 | Powder | Bulk ingredients | October 4, 2020 |
| Esomeprazole sodium | 65372-1139 | Powder | Bulk ingredients | May 31, 2020 |
| Apremilast | 65372-1204 | Powder | Bulk ingredients | January 17, 2020 |
| Vilazodone hydrochloride | 65372-1203 | Powder | Bulk ingredients | July 26, 2019 |
| Mirabegron | 65372-1202 | Powder | Bulk ingredients | July 26, 2019 |
| Brexpiprazole | 65372-1201 | Powder | Bulk ingredients | December 31, 2018 |
| Vildagliptin | 65372-1200 | Powder | Bulk ingredients | March 31, 2018 |
| Ticagrelor | 65372-1198 | Powder | Bulk ingredients | March 30, 2018 |
| Deferasirox | 65372-1164 | Powder | Bulk ingredients | March 1, 2018 |
| Pirfenidone | 65372-1197 | Powder | Bulk ingredients | January 24, 2018 |
| Apixaban | 65372-1196 | Powder | Bulk ingredients | November 29, 2017 |
| Rivaroxaban | 65372-1193 | Powder | Bulk ingredients | March 31, 2017 |
| Niacin | 65372-1194 | Powder | Bulk ingredients | March 28, 2017 |
| Dabigatran etexilate mesylate | 65372-1195 | Powder | Bulk ingredients | March 20, 2017 |
| Lurasidone hydrochloride | 65372-1192 | Powder | Bulk ingredients | March 20, 2017 |
| Perphenazine | 65372-1191 | Powder | Bulk ingredients | March 20, 2017 |
| Ranolazine | 65372-1190 | Powder | Bulk ingredients | November 30, 2016 |
| Azithromycin dihydrate | 65372-1129 | Powder | Bulk ingredients | November 30, 2016 |
| Tramadol hydrochloride | 65372-1112 | Powder | Bulk ingredients | November 30, 2016 |
| Febuxostat | 65372-1189 | Powder | Bulk ingredients | March 30, 2016 |
| Olanzapine | 65372-1183 | Powder | Bulk ingredients | February 29, 2016 |
| Sitagliptin phosphate monohydrate | 65372-1188 | Powder | Bulk ingredients | December 18, 2015 |
| Lacosamide | 65372-1186 | Powder | Bulk ingredients | January 23, 2015 |
| Zopiclone | 65372-1185 | Powder | Bulk ingredients | January 23, 2015 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.